<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37847581</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus A6 2C protein antagonizes IFN-β production through MDA5 and RIG-I depletion.</ArticleTitle><Pagination><StartPage>e0107523</StartPage><MedlinePgn>e0107523</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e01075-23</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.01075-23</ELocationID><Abstract><AbstractText>Coxsackievirus A6 (CV-A6) is a major emerging pathogen associated with atypical hand, foot, and mouth disease and can cause serious complications such as encephalitis, acute flaccid paralysis, and neurorespiratory syndrome. Therefore, revealing the associated pathogenic mechanisms could benefit the control of CV-A6 infections. In this study, we demonstrate that the nonstructural 2C<sub>CV-A6</sub> suppresses IFN-β production, which supports CV-A6 infection. This is achieved by depleting RNA sensors such as melanoma differentiation-associated gene 5 and retinoic acid-inducible gene I (RIG-I) through the lysosomal pathway. Such a function is shared by 2C<sub>EV-A71</sub> and 2C<sub>CV-B3</sub> but not 2C<sub>CV-A16</sub>, suggesting the latter might have an alternative way to promote viral replication. This study broadens our understanding of enterovirus 2C protein regulation of the RIG-I-like receptor signaling pathway and reveals a novel mechanism by which CV-A6 and other enteroviruses evade the host innate immune response. These findings on 2C may provide new therapeutic targets for the development of effective inhibitors against CV-A6 and other enterovirus infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shao-Hua</ForeName><Initials>S-H</Initials><Identifier Source="ORCID">0009-0001-6847-4494</Identifier><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Juan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5848-8668</Identifier><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jinghua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yifei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hua</LastName><ForeName>Shucheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ke</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5833-1852</Identifier><AffiliationInfo><Affiliation>Center of Infectious Diseases and Pathogen Biology, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, First Hospital of Jilin University , Changchun, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81902049</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>32170146</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>32170140</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>20200201525JC</GrantID><Agency>The Science and Technology Department of Jilin Province</Agency><Country /></Grant><Grant><GrantID>20220101285JC</GrantID><Agency>The Science and Technology Department of Jilin Province</Agency><Country /></Grant><Grant><GrantID>20210101314JC</GrantID><Agency>The Science and Technology Department of Jilin Province</Agency><Country /></Grant><Grant><GrantID>20220101301JC</GrantID><Agency>The Science and Technology Department of Jilin Province</Agency><Country /></Grant><Grant><GrantID>2017TD-08</GrantID><Agency>The Fundamental Research Funds for the Central Universities</Agency><Country /></Grant><Grant><GrantID>20102209</GrantID><Agency>The Key Laboratory of Molecular Virology, Jilin Province</Agency><Country /></Grant><Grant><GrantID>2020-CXQ-02</GrantID><Agency>The First Hospital of Jilin University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C076023">2C protein, viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452820">RIGI protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2C protein</Keyword><Keyword MajorTopicYN="N">HFMD</Keyword><Keyword MajorTopicYN="N">IFN-β</Keyword><Keyword MajorTopicYN="N">MDA5</Keyword><Keyword MajorTopicYN="N">RIG-I</Keyword><Keyword MajorTopicYN="N">coxsackievirus A6</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>17</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>17</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37847581</ArticleId><ArticleId IdType="pmc">PMC10688345</ArticleId><ArticleId IdType="doi">10.1128/jvi.01075-23</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Repass GL, Palmer WC, Stancampiano FF. 2014. Hand, foot, and mouth disease: identifying and managing an acute viral syndrome. Cleve Clin J Med 81:537–543. doi:10.3949/ccjm.81a.13132</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.81a.13132</ArticleId><ArticleId IdType="pubmed">25183845</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamau E, Nguyen D, Celma C, Blomqvist S, Horby P, Simmonds P, Harvala H. 2021. Seroprevalence and virologic surveillance of enterovirus 71 and coxsackievirus A6, United Kingdom, 2006-2017. Emerg Infect Dis 27:2261–2268. doi:10.3201/eid2709.204915</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2709.204915</ArticleId><ArticleId IdType="pmc">PMC8386771</ArticleId><ArticleId IdType="pubmed">34423767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanbayashi D, Kaida A, Yamamoto SP, Hirai Y, Kubo H, Fujimori R, Hakui N, Hirokawa H, Iritani N. 2017. Impact of coxsackievirus A6 emergence on hand, foot, and mouth disease epidemic in Osaka City, Japan. J Med Virol 89:2116–2121. doi:10.1002/jmv.24905</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24905</ArticleId><ArticleId IdType="pubmed">28771766</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Rui J, Deng Z, Zhang Y, Qian K, Zhu C, Yu S, Tu J, Xia W, Zhu Q, Chen S, Chen T, Zhou X. 2021. Surveillance, epidemiology and impact of EV-A71 vaccination on hand, foot, and mouth disease in Nanchang, China, 2010-2019. Front Microbiol 12:811553. doi:10.3389/fmicb.2021.811553</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.811553</ArticleId><ArticleId IdType="pmc">PMC8770912</ArticleId><ArticleId IdType="pubmed">35069515</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J-F, Xu S, Zhang Y, Zhu S-Y, Wu D-L, Yang X-D, Liu H, Sun B-X, Wu X-Y, Qin C-F. 2014. Hand, foot, and mouth disease outbreak caused by coxsackievirus A6, China, 2013. J Infect 69:303–305. doi:10.1016/j.jinf.2014.03.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2014.03.015</ArticleId><ArticleId IdType="pubmed">24704297</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J-S, Dong X-G, Qin M, Feng H-R, Yang J-Y, Li R-X, Zhang J-J, Zheng L-S. 2016. Outbreak of hand, foot, and mouth disease caused by coxsackievirus A6 in a Juku in Fengtai District, Beijing, China, 2015. Springerplus 5:1650. doi:10.1186/s40064-016-3307-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40064-016-3307-x</ArticleId><ArticleId IdType="pmc">PMC5033802</ArticleId><ArticleId IdType="pubmed">27733967</ArticleId></ArticleIdList></Reference><Reference><Citation>He S, Chen M, Wu W, Yan Q, Zhuo Z, Su X, Zhang S, Ge S, Xia N. 2018. An emerging and expanding clade accounts for the persistent outbreak of coxsackievirus A6-associated hand, foot, and mouth disease in China since 2013. Virology 518:328–334. doi:10.1016/j.virol.2018.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2018.03.012</ArticleId><ArticleId IdType="pubmed">29587191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L, Maimaiti H, Zhou L, Gao J, Lu Y. 2022. Changing serotypes of hand, foot and mouth disease in Shanghai, 2017-2019. Gut Pathog 14:12. doi:10.1186/s13099-022-00485-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13099-022-00485-1</ArticleId><ArticleId IdType="pmc">PMC8935267</ArticleId><ArticleId IdType="pubmed">35313977</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Zhou Y, Lu H, Yang H, Feng Q, Dai Y, Chen L, Yu S, Yao X, Zhang H, Jiang M, Wang Y, Han N, Hu G, He Y. 2015. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009-2013. J Med Virol 87:1471–1479. doi:10.1002/jmv.24200</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24200</ArticleId><ArticleId IdType="pubmed">25951788</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91–107. doi:10.1111/j.1574-6976.2002.tb00601.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. 2010. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778–790. doi:10.1016/S1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Norder H, De Palma AM, Selisko B, Costenaro L, Papageorgiou N, Arnan C, Coutard B, Lantez V, De Lamballerie X, Baronti C, Solà M, Tan J, Neyts J, Canard B, Coll M, Gorbalenya AE, Hilgenfeld R. 2011. Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antiviral Res 89:204–218. doi:10.1016/j.antiviral.2010.12.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2010.12.007</ArticleId><ArticleId IdType="pubmed">21236302</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan H, Tian J, Qin B, Wojdyla JA, Wang B, Zhao Z, Wang M, Cui S. 2017. Crystal structure of 2C helicase from enterovirus 71. Sci Adv 3:e1602573. doi:10.1126/sciadv.1602573</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1602573</ArticleId><ArticleId IdType="pmc">PMC5409451</ArticleId><ArticleId IdType="pubmed">28508043</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho MW, Teterina N, Egger D, Bienz K, Ehrenfeld E. 1994. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 202:129–145. doi:10.1006/viro.1994.1329</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1329</ArticleId><ArticleId IdType="pubmed">8009827</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldabe R, Carrasco L. 1995. Induction of membrane proliferation by poliovirus proteins 2C and 2BC. Biochem Biophys Res Commun 206:64–76. doi:10.1006/bbrc.1995.1010</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1995.1010</ArticleId><ArticleId IdType="pubmed">7818552</ArticleId></ArticleIdList></Reference><Reference><Citation>Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E. 1997. Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol 71:8962–8972. doi:10.1128/JVI.71.12.8962-8972.1997</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.71.12.8962-8972.1997</ArticleId><ArticleId IdType="pmc">PMC230196</ArticleId><ArticleId IdType="pubmed">9371552</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhy DA, Giddings Jr TH, Kirkegaard K. 2000. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol 74:8953–8965. doi:10.1128/jvi.74.19.8953-8965.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.19.8953-8965.2000</ArticleId><ArticleId IdType="pmc">PMC102091</ArticleId><ArticleId IdType="pubmed">10982339</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JP, Baltimore D. 1988. Isolation of poliovirus 2C mutants defective in viral RNA synthesis. J Virol 62:4016–4021. doi:10.1128/JVI.62.11.4016-4021.1988</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.62.11.4016-4021.1988</ArticleId><ArticleId IdType="pmc">PMC253830</ArticleId><ArticleId IdType="pubmed">2845120</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieder E, Paul AV, Kim DW, van Boom JH, Wimmer E. 2000. Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation. J Virol 74:10371–10380. doi:10.1128/jvi.74.22.10371-10380.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.22.10371-10380.2000</ArticleId><ArticleId IdType="pmc">PMC110911</ArticleId><ArticleId IdType="pubmed">11044081</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Peters J, Mugavero J, Yin J, van Boom JH, Wimmer E. 2003. Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus. J Virol 77:891–904. doi:10.1128/jvi.77.2.891-904.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.2.891-904.2003</ArticleId><ArticleId IdType="pmc">PMC140777</ArticleId><ArticleId IdType="pubmed">12502805</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W-F, Yang S-Y, Wu B-W, Jheng J-R, Chen Y-L, Shih C-H, Lin K-H, Lai H-C, Tang P, Horng J-T. 2007. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J Biol Chem 282:5888–5898. doi:10.1074/jbc.M611145200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611145200</ArticleId><ArticleId IdType="pubmed">17182608</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Wang P, Wang G-C, Yang J, Sun X, Wu W, Qiu Y, Shu T, Zhao X, Yin L, Qin C-F, Hu Y, Zhou X. 2015. Human enterovirus nonstructural protein 2CATPase functions as both an RNA helicase and ATP-independent RNA chaperone. PLoS Pathog 11:e1005067. doi:10.1371/journal.ppat.1005067</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005067</ArticleId><ArticleId IdType="pmc">PMC4517893</ArticleId><ArticleId IdType="pubmed">26218680</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance LM, Moscufo N, Chow M, Heinz BA. 1997. Poliovirus 2C region functions during encapsidation of viral RNA. J Virol 71:8759–8765. doi:10.1128/JVI.71.11.8759-8765.1997</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.71.11.8759-8765.1997</ArticleId><ArticleId IdType="pmc">PMC192341</ArticleId><ArticleId IdType="pubmed">9343235</ArticleId></ArticleIdList></Reference><Reference><Citation>Verlinden Y, Cuconati A, Wimmer E, Rombaut B. 2000. The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system. Antiviral Res 48:61–69. doi:10.1016/s0166-3542(00)00119-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0166-3542(00)00119-4</ArticleId><ArticleId IdType="pubmed">11080541</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, Jiang P. 2010. Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog 6:e1001066. doi:10.1371/journal.ppat.1001066</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001066</ArticleId><ArticleId IdType="pmc">PMC2928791</ArticleId><ArticleId IdType="pubmed">20865167</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Jiang P, Sand C, Paul AV, Wimmer E. 2012. Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for morphogenesis. J Virol 86:9964–9975. doi:10.1128/JVI.00914-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00914-12</ArticleId><ArticleId IdType="pmc">PMC3446611</ArticleId><ArticleId IdType="pubmed">22761387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ma HC, Wimmer E, Jiang P, Paul AV. 2014. A C-terminal, cysteine-rich site in poliovirus 2C(ATPase) is required for morphogenesis. J Gen Virol 95:1255–1265. doi:10.1099/vir.0.062497-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.062497-0</ArticleId><ArticleId IdType="pmc">PMC4027037</ArticleId><ArticleId IdType="pubmed">24558221</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez PL, Carrasco L. 1993. Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem 268:8105–8110. doi:10.1016/S0021-9258(18)53068-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)53068-4</ArticleId><ArticleId IdType="pubmed">8385138</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzayan C, Wimmer E. 1994. Biochemical studies on poliovirus polypeptide 2C: evidence for ATPase activity. Virology 199:176–187. doi:10.1006/viro.1994.1110</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1994.1110</ArticleId><ArticleId IdType="pubmed">8116241</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbalenya AE, Koonin EV. 1989. Viral proteins containing the purine NTP-binding sequence pattern. Nucleic Acids Res 17:8413–8440. doi:10.1093/nar/17.21.8413</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/17.21.8413</ArticleId><ArticleId IdType="pmc">PMC335016</ArticleId><ArticleId IdType="pubmed">2555771</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfister T, Wimmer E. 1999. Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J Biol Chem 274:6992–7001. doi:10.1074/jbc.274.11.6992</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.11.6992</ArticleId><ArticleId IdType="pubmed">10066753</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-H, Wang K, Zhao K, Hua S-C, Du J. 2020. The structure, function, and mechanisms of action of enterovirus non-structural protein 2C. Front Microbiol 11:615965. doi:10.3389/fmicb.2020.615965</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.615965</ArticleId><ArticleId IdType="pmc">PMC7767853</ArticleId><ArticleId IdType="pubmed">33381104</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol Rev 227:75–86. doi:10.1111/j.1600-065X.2008.00737.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00737.x</ArticleId><ArticleId IdType="pmc">PMC5489343</ArticleId><ArticleId IdType="pubmed">19120477</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. 2006. Innate immune recognition of viral infection. Nat Immunol 7:131–137. doi:10.1038/ni1303</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1303</ArticleId><ArticleId IdType="pubmed">16424890</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. 2007. Recognition of viruses by innate immunity. Immunol Rev 220:214–224. doi:10.1111/j.1600-065X.2007.00562.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2007.00562.x</ArticleId><ArticleId IdType="pubmed">17979849</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K-R, Ling P. 2019. Interplays between enterovirus A71 and the innate immune system. J Biomed Sci 26:95. doi:10.1186/s12929-019-0596-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0596-8</ArticleId><ArticleId IdType="pmc">PMC6886175</ArticleId><ArticleId IdType="pubmed">31787104</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Lei C, Xu Z, Yang F, Liu H, Zhu Z, Li S, Liu X, Shu H, Zheng H. 2016. Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-beta signaling pathway. Sci Rep 6:21888. doi:10.1038/srep21888</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21888</ArticleId><ArticleId IdType="pmc">PMC4756384</ArticleId><ArticleId IdType="pubmed">26883855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Z, Fang L, Jing H, Zeng S, Wang D, Liu L, Zhang H, Luo R, Chen H, Xiao S. 2014. Porcine epidemic diarrhea virus nucleocapsid protein antagonizes beta interferon production by sequestering the interaction between IRF3 and TBK1. J Virol 88:8936–8945. doi:10.1128/JVI.00700-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00700-14</ArticleId><ArticleId IdType="pmc">PMC4136253</ArticleId><ArticleId IdType="pubmed">24872591</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo Y-M, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, Gale Jr M. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82:335–345. doi:10.1128/JVI.01080-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01080-07</ArticleId><ArticleId IdType="pmc">PMC2224404</ArticleId><ArticleId IdType="pubmed">17942531</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Zhang Z, Zheng Z, Ke X, Zhang X, Li Q, Liu Y, Bai B, Mao P, Hu Q, Wang H. 2013. Human bocavirus VP2 upregulates IFN-beta pathway by inhibiting ring finger protein 125-mediated ubiquitination of retinoic acid-inducible gene-I. J Immunol 191:660–669. doi:10.4049/jimmunol.1202933</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202933</ArticleId><ArticleId IdType="pubmed">23772026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, Lei C, He X, Zhang L, Tien P, Shu HB. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538–550. doi:10.1016/j.immuni.2008.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2008.09.003</ArticleId><ArticleId IdType="pubmed">18818105</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Xie J, Xu S, Bi Y, Li X, Zhang H, Idris A, Bai J, Feng R. 2021. Encephalomyocarditis virus abrogates the interferon beta signaling pathway via its structural protein VP2. J Virol 95:e01590-20. doi:10.1128/JVI.01590-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01590-20</ArticleId><ArticleId IdType="pmc">PMC8094936</ArticleId><ArticleId IdType="pubmed">33328314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Chen CJ, Wang RYL, Huang HI, Lin YH, Tam EH, Tu WJ, Wu SE, Shih SR. 2019. Role of enteroviral RNA-dependent RNA polymerase in regulation of MDA5-mediated beta interferon activation. J Virol 93:e00132-19. doi:10.1128/JVI.00132-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00132-19</ArticleId><ArticleId IdType="pmc">PMC6498057</ArticleId><ArticleId IdType="pubmed">30814289</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. 2008. MDA5/RIG-I and virus recognition. Curr Opin Immunol 20:17–22. doi:10.1016/j.coi.2008.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2008.01.002</ArticleId><ArticleId IdType="pubmed">18272355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Li H, Zhang Z, Meng J, Mao D, Bai B, Lu B, Mao P, Hu Q, Wang H. 2011. Enterovirus 71 2C protein inhibits TNF-alpha-mediated activation of NF-kappaB by suppressing IkappaB kinase beta phosphorylation. J Immunol 187:2202–2212. doi:10.4049/jimmunol.1100285</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100285</ArticleId><ArticleId IdType="pubmed">21810613</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Zheng Z, Liu Y, Zhang Z, Liu Q, Meng J, Ke X, Hu Q, Wang H. 2016. 2C proteins of enteroviruses suppress Ikkbeta phosphorylation by recruiting protein phosphatase 1. J Virol 90:5141–5151. doi:10.1128/JVI.03021-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03021-15</ArticleId><ArticleId IdType="pmc">PMC4859720</ArticleId><ArticleId IdType="pubmed">26962213</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji L, Yang E, He S, Jin Y, Chen D. 2021. Enterovirus 2C protein suppresses Ikkalpha phosphorylation by recruiting Ikkbeta and Ikkalpha into viral inclusion bodies. Viral Immunol 34:218–226. doi:10.1089/vim.2020.0173</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2020.0173</ArticleId><ArticleId IdType="pubmed">33226912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin R, Heylbroeck C, Pitha PM, Hiscott J. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18:2986–2996. doi:10.1128/MCB.18.5.2986</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.18.5.2986</ArticleId><ArticleId IdType="pmc">PMC110678</ArticleId><ArticleId IdType="pubmed">9566918</ArticleId></ArticleIdList></Reference><Reference><Citation>Strähle L, Garcin D, Le Mercier P, Schlaak JF, Kolakofsky D. 2003. Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner. J Virol 77:7903–7913. doi:10.1128/jvi.77.14.7903-7913.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.77.14.7903-7913.2003</ArticleId><ArticleId IdType="pmc">PMC161935</ArticleId><ArticleId IdType="pubmed">12829830</ArticleId></ArticleIdList></Reference><Reference><Citation>Mibayashi M, Martínez-Sobrido L, Loo Y-M, Cárdenas WB, Gale M, García-Sastre A. 2007. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81:514–524. doi:10.1128/JVI.01265-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01265-06</ArticleId><ArticleId IdType="pmc">PMC1797471</ArticleId><ArticleId IdType="pubmed">17079289</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo Y-M, Gale Jr M. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680–692. doi:10.1016/j.immuni.2011.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.05.003</ArticleId><ArticleId IdType="pmc">PMC3177755</ArticleId><ArticleId IdType="pubmed">21616437</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481–485. doi:10.1038/nature09907</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09907</ArticleId><ArticleId IdType="pmc">PMC3409588</ArticleId><ArticleId IdType="pubmed">21478870</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorimitsu T, Klionsky DJ. 2005. Autophagy: molecular machinery for self-eating. Cell Death Differ 12 Suppl 2:1542–1552. doi:10.1038/sj.cdd.4401765</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cdd.4401765</ArticleId><ArticleId IdType="pmc">PMC1828868</ArticleId><ArticleId IdType="pubmed">16247502</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikic I. 2017. Proteasomal and autophagic degradation systems. Annu Rev Biochem 86:193–224. doi:10.1146/annurev-biochem-061516-044908</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-061516-044908</ArticleId><ArticleId IdType="pubmed">28460188</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M, Kapell S, Hertz NT, Wu X, Bell K, Ashbrook AW, Mark MT, Zebroski HA, Neal ML, Flodström-Tullberg M, MacDonald MR, Aitchison JD, Molina H, Rice CM. 2020. Defining the proteolytic landscape during enterovirus infection. PLoS Pathog 16:e1008927. doi:10.1371/journal.ppat.1008927</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008927</ArticleId><ArticleId IdType="pmc">PMC7549765</ArticleId><ArticleId IdType="pubmed">32997711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui Y, Su J, Wang H, Chang J, Wang S, Zheng W, Cai Y, Wei W, Gordy JT, Markham R, Kong W, Zhang W, Yu X-F. 2017. Disruption of MDA5-mediated innate immune responses by the 3C proteins of coxsackievirus A16, coxsackievirus A6, and enterovirus D68. J Virol 91:e00546-17. doi:10.1128/JVI.00546-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00546-17</ArticleId><ArticleId IdType="pmc">PMC5469270</ArticleId><ArticleId IdType="pubmed">28424289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J, Zhao Y, Du J, Wang Y, Wang S, Wang Q, Zhao X, Xu W, Zhao K. 2022. RNA sensor MDA5 suppresses LINE-1 retrotransposition by regulating the promoter activity of LINE-1 5'-UTR. Mob DNA 13:10. doi:10.1186/s13100-022-00268-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13100-022-00268-0</ArticleId><ArticleId IdType="pmc">PMC9003951</ArticleId><ArticleId IdType="pubmed">35414110</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y, Sata T, Tokunaga K. 2009. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J Biol Chem 284:35060–35072. doi:10.1074/jbc.M109.058305</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.058305</ArticleId><ArticleId IdType="pmc">PMC2787367</ArticleId><ArticleId IdType="pubmed">19837671</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee R, Weidman MK, Echeverri A, Kundu P, Dasgupta A. 2004. Regulation of poliovirus 3C protease by the 2C polypeptide. J Virol 78:9243–9256. doi:10.1128/JVI.78.17.9243-9256.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.17.9243-9256.2004</ArticleId><ArticleId IdType="pmc">PMC506913</ArticleId><ArticleId IdType="pubmed">15308719</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Ning S, Su X, Liu X, Wang H, Liu Y, Zheng W, Zheng B, Yu XF, Zhang W. 2018. Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G. Nucleic Acids Res 46:11514–11527. doi:10.1093/nar/gky840</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky840</ArticleId><ArticleId IdType="pmc">PMC6265463</ArticleId><ArticleId IdType="pubmed">30247716</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Liu X, Wang S, Li J, Hou M, Liu G, Zhang W, Yu XF. 2016. Identification of a nucleotide in 5' untranslated region contributing to virus replication and virulence of coxsackievirus A16. Sci Rep 6:20839. doi:10.1038/srep20839</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20839</ArticleId><ArticleId IdType="pmc">PMC4748407</ArticleId><ArticleId IdType="pubmed">26861413</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-H, Wang A, Liu P-P, Zhang W-Y, Du J, Xu S, Liu G-C, Zheng B-S, Huan C, Zhao K, Yu X-F. 2018. Divergent pathogenic properties of circulating coxsackievirus A6 associated with emerging hand, foot, and mouth disease. J Virol 92:e00303-18. doi:10.1128/JVI.00303-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00303-18</ArticleId><ArticleId IdType="pmc">PMC5952127</ArticleId><ArticleId IdType="pubmed">29563294</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K, Emdad L, Bhoopathi P, Fisher PB, Lloyd RE, van Kuppeveld FJM. 2014. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 88:3369–3378. doi:10.1128/JVI.02712-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Liu X, Ma Y, Sun Z, Yang Y, Jin Q, He B, Wang J. 2010. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84:8051–8061. doi:10.1128/JVI.02491-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02491-09</ArticleId><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo R-L, Kao L-T, Lin S-J, Wang R-L, Shih S-R. 2013. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One 8:e63431. doi:10.1371/journal.pone.0063431</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737. doi:10.1038/ni1087</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1087</ArticleId><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM, Battini R, Beresford MW, et al. . 2014. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 46:503–509. doi:10.1038/ng.2933</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2933</ArticleId><ArticleId IdType="pmc">PMC4004585</ArticleId><ArticleId IdType="pubmed">24686847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Li X, Li P, Pan Z, Ding Y, Zou D, Zheng L, Zhang Y, Li L, Xiao L, Song B, Cui Y, Cao H, Zhang H. 2016. Enterovirus 71 inhibits cellular type I interferon signaling by inhibiting host RIG-I ubiquitination. Microb Pathog 100:84–89. doi:10.1016/j.micpath.2016.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2016.09.001</ArticleId><ArticleId IdType="pubmed">27633794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhu C, Bao W, Zhao K, Niu J, Yu X-F, Zhang W. 2012. Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS One 7:e32405. doi:10.1371/journal.pone.0032405</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032405</ArticleId><ArticleId IdType="pmc">PMC3315555</ArticleId><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Zhu R, Yang Y, Chi Y, Yin J, Tang X, Yu L, Zhang C, Huang Z, Zhou D. 2015. Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou City, Jiangsu province, China, in 2012-2013. Emerg Microbes Infect 4:e12. doi:10.1038/emi.2015.12</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2015.12</ArticleId><ArticleId IdType="pmc">PMC4345287</ArticleId><ArticleId IdType="pubmed">26038764</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, Guan W, Guo Y, Yu H, Zhang X, Cheng R, Wang Z, Zhang Z, Zhang J, Li H, Zhuang Y, Zhang H, Lu Z, Li M, Yu H, Bao Y, Hu Y, Yao Z. 2015. A novel recombinant lineage's contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012-2013. Sci Rep 5:11700. doi:10.1038/srep11700</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11700</ArticleId><ArticleId IdType="pmc">PMC4485158</ArticleId><ArticleId IdType="pubmed">26121916</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497. doi:10.1093/oxfordjournals.aje.a118408</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Du J, Peng Y, Li P, Wang S, Wang Y, Hou J, Kang J, Zheng W, Hua S, Yu X-F. 2018. LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways. J Autoimmun 90:105–115. doi:10.1016/j.jaut.2018.02.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.02.007</ArticleId><ArticleId IdType="pubmed">29525183</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J, Ma H, Xu L, An D, Sun S, Huang X, Kong W, Jiang C. 2013. Development of a coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum. J Virol Methods 187:362–367. doi:10.1016/j.jviromet.2012.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2012.11.014</ArticleId><ArticleId IdType="pmc">PMC7112850</ArticleId><ArticleId IdType="pubmed">23178532</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Xie Y, Li C, Wang L, He C, Zhang Y, Yuan J, Luo J, Liu X, Xiu Y, Li H, Gritsenko M, Nakayasu ES, Feng Y, Luo Z-Q. 2021. The Legionella effector SdjA is a bifunctional enzyme that distinctly regulates phosphoribosyl ubiquitination. mBio 12:e0231621. doi:10.1128/mBio.02316-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02316-21</ArticleId><ArticleId IdType="pmc">PMC8546864</ArticleId><ArticleId IdType="pubmed">34488448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Fu J, Liu S, Wang L, Qiu J, van Schaik EJ, Samuel JE, Song L, Luo Z-Q. 2022. Coxiella burnetii inhibits host immunity by a protein phosphatase adapted from glycolysis. Proc Natl Acad Sci U S A 119:e2110877119. doi:10.1073/pnas.2110877119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2110877119</ArticleId><ArticleId IdType="pmc">PMC8740755</ArticleId><ArticleId IdType="pubmed">34930823</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>